Isolation and characterization of a novel Escherichia coli Kayfunavirus phage DY1

Xiaoming Yuan1, Shuhong Zhang2, Juan Wang3

  • 1Department of Food Science & Technology, Institute of Food Safety & Nutrition, Jinan University, Huangpu Ave. 601, Guangzhou 510632, China; Guangdong Institute of Microbiology, State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Safety and Health, Guangdong Open Laboratory of Applied Microbiology, Guangdong Academy of Sciences, Xianlie Zhong Road 100 #, 58th Building, Guangzhou, 510070, China; College of Life Sciences, Jinan University, Guangzhou, China.

Virus Research
|December 28, 2020
PubMed

Insights

A novel phage, DY1, targeting Escherichia coli was identified. This phage, a new member of the Kayfunavirus genus, shows stability and potential for phage therapy applications.

Area of Science:

  • Microbiology
  • Virology
  • Genomics

Background:

  • Increasing antibiotic resistance necessitates alternative antibacterial strategies.
  • Bacteriophages (phages) offer precise bacterial targeting, but require extensive characterization.
  • Escherichia coli exhibits high diversity, with existing phages unable to target all serotypes.

Purpose of the Study:

  • To identify and characterize a novel phage specific to Escherichia coli.
  • To expand the phage library for potential therapeutic applications.
  • To enhance understanding of phage-host interactions within E. coli.

Main Methods:

  • Isolation and characterization of a novel E. coli-specific phage, named DY1.
  • Whole-genome sequencing and analysis of phage DY1.
  • Comparative genomic and phylogenetic analyses with known phages.
  • Stability testing across various temperatures and pH levels.

Main Results:

  • Phage DY1, belonging to the Autographiviridae family (derived from Podoviridae), was identified.
  • DY1's genome is 39,817 bp with 54 putative open reading frames.
  • Phylogenetic analysis revealed DY1 as a novel Kayfunavirus phage, with ANI values below 0.82 against known phages.
  • DY1 demonstrated stability at temperatures from 20-50 °C and pH 5-11.

Conclusions:

  • Phage DY1 represents a novel species within the Kayfunavirus genus.
  • DY1 exhibits favorable stability characteristics for potential therapeutic use.
  • This discovery contributes to the growing phage library for combating E. coli infections.

Related Concept Videos

Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
792
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
456
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
75.1K